Granulocyte colony stimulating factor treatment for alloimmune neonatal neutropenia

Arch Dis Child Fetal Neonatal Ed. 1996 Jul;75(1):F57-8. doi: 10.1136/fn.75.1.f57.

Abstract

Granulocyte colony stimulating factor (G-CSF) treatment was successfully used in three preterm infants with alloimmune neonatal neutropenia (AINN). Two infants had persistent neutropenia despite treatment with intravenous immunoglobulin and random donor granulocyte transfusions for presumed sepsis. Neutrophil counts returned to normal with G-CSF treatment; the response was least convincing in one infant with fulminant necrotising enterocolits. It is suggested that treatment with G-CSF be considered early for the treatment of infants with AINN.

Publication types

  • Case Reports

MeSH terms

  • Antibodies / blood
  • Female
  • Fetal Blood / immunology
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Humans
  • Infant, Newborn
  • Infant, Premature, Diseases / immunology
  • Infant, Premature, Diseases / therapy*
  • Injections, Subcutaneous
  • Leukocyte Count
  • Male
  • Neutropenia / immunology
  • Neutropenia / therapy*
  • Neutrophils / immunology

Substances

  • Antibodies
  • Granulocyte Colony-Stimulating Factor